Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Alexion Pharm Inc (ALXN) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines as of [[ item.timeDateDisplayLong ]]
SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 6, 2016 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company")...

INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) & Lead Plaintiff Deadline - January 17, 2017

NEW YORK, NY / ACCESSWIRE / December 5, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company")...

Alexion Presents Data from Ultra-Rare Blood Disorder Study

Alexion Pharmaceuticals (ALXN) presented new data from a dose-escalation study on ALXN1210 in patients with paroxysmal nocturnal hemoglobinuria at ASH.

New Data from ALXN1210 Dose-Escalation Study Presented at ASH Show Rapid and Sustained Reductions in LDH in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) announced today that new data from an ongoing Phase 1/2 dose-escalation study of ALXN1210 in patients with paroxysmal nocturnal hemoglobinuria...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alexion Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ALXN

Pomerantz LLP announces that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") (NASDAQ:ALXN) and certain of its officers. The class action, filed...

SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 1, 2016 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company")...

Lifshitz & Miller Law Firm Announces Investigation of Alexion Pharmaceuticals, Inc., Blue Nile, Inc., Hill International, Inc., InfuSystem Holdings Inc., Rent-A-Center, Inc., Treehouse Foods, Inc. and Viking Investments Group, Inc.

Alexion Pharmaceuticals, Inc. (ALXN)

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / November 30, 2016 / Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") (Nasdaq: ALXN)....

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alexion Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 -- ALXN

NEW YORK, NY--(Marketwired - November 30, 2016) - The following statement is being issued by Levi & Korsinsky, LLP:

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alexion Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 -- ALXN

NEW YORK, NY--(Marketwired - November 30, 2016) - The following statement is being issued by Levi & Korsinsky, LLP:

Lawsuit for Investors in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares announced by Shareholders Foundation

The Shareholders Foundation, Inc. announces that a lawsuit was filed in New York on behalf of certain purchasers of shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) over alleged Securities Laws Violations...

SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Alexion Pharmaceuticals, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline - ALXN

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of...

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) and Lead Plaintiff Deadline: January 17, 2017

NEW YORK, NY / ACCESSWIRE / November 24, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. ("Alexion" or the...

Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola

Focus is back on pipeline and regulatory updates with the end of the third quarter earnings season and elections.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / November 22, 2016 / Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") (Nasdaq: ALXN)....

Robbins Arroyo LLP: Alexion Pharmaceuticals, Inc. (ALXN) Misled Shareholders According to a Recently Filed Class Action

Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Alexion Pharmaceuticals, Inc. (NASDAQGS: ALXN) in the U.S. District Court for the...

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. Limited and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / November 22, 2016 / Lundin Law PC , a shareholder rights firm, announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company")...

Lockridge Grindal Nauen P.L.L.P. Announces Filing of a Securities Class Action Against Alexion Pharmaceuticals, Inc.

Lockridge Grindal Nauen P.L.L.P. announces that a class action has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Alexion Pharmaceuticals,...

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alexion Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") (Nasdaq: ALXN). Investors who purchased or...

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) and Lead Plaintiff Deadline: January 17, 2017

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") (NASDAQ:ALXN)...

Van Meerten Stock Picks

5 NAsdaq 100 Stocks for Momentum Investors
Today I wanted to find the 5 NASDAQ 100 Index stocks that had the most consistent momentum so I used Barchart to sort the NASDAQ 100 Index stocks first by the most frequent number of new highs in the last month.
PCAR -0.96 , TMUS -1.79 , AMAT -0.54 , SBUX +0.05 , AAL +1.14
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Dec E-mini S&Ps ( ESZ16 +0.03%) are up +0.03% as the market consolidates following Thursday's rally to an all-time high. European stocks are up +0.31% at an 11-month high on positive carry-over from the ECB's... Read More

Chart of the Day

KMG Chemicals (KMG) is the Barchart Chart of the Day.  The specialty chemical company has a Trend Spotter buy signal, a Weighted Alpha of 56.07+ and gained 81.25% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures are trading steady to 2 cents higher this morning ahead of the USDA reports scheduled for 11 AM CST. The weekly USDA Export Sales report showed sales for the week ending 12/1 were up 96% vs. Thanksgiving week and up 45% vs. the same we...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.